AGP Executive Report
Last update: 3 hours agoBiotech in Cayman-linked spotlight: Silexion Therapeutics says it has moved SIL204 into an active Phase 2/3 pancreatic cancer trial, with trial initiation at Tel Aviv Sourasky Medical Center after regulatory authorizations in Israel and Germany, plus new preclinical immune-sensitization data and GMP clinical supply manufacturing with a Cayman-based CDMO partner. Local conservation science: The National Trust for the Cayman Islands broke ground on a new Blue Iguana Conservation office and laboratory at Queen Elizabeth II Botanic Park, adding a dedicated lab for medical exams, data collection and research, incubators, education and collections space to strengthen the programme’s “living classroom.” STEM education pipeline: Dart’s 2026 Work-X programme placed 31 Caymanian students into hands-on projects across 13 business areas, including IT building an online booking solution for a hospitality portfolio. AI buildathon momentum: Future Caribbean reports 450-plus builders from 39 countries joined its Agentic AI buildathon, targeting deployable solutions across sectors like health, finance, tourism, logistics and climate resilience. AI infrastructure push: Oxbridge Re launched AI GridWorks, an AI data-centre development-and-operations platform aiming for 10–100 MW projects, starting with ~50 MW facilities. Citizen science for bats: The Department of Environment is recruiting more volunteers for Bat Count Cayman, expanding surveys of velvety free-tailed bats across Grand Cayman.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
